EMJ Podcast: Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC - European Medical Journal

EMJ Podcast: Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC

Bonus Episode | 13 MAY 2021

Benefits of Neoadjuvant use of Mitomycin C for the Management of NMIBC

This episode, sponsored by medac, is a discussion around non-muscle-invasive bladder cancer (NMIBC). We hear from Professor Jørgen Bjerggaard Jensen, who leads clinical research in bladder cancer at the Department of Urology, Aarhus University Hospital, as he explores the management of NMIBC through the neoadjuvant use of Mitomycin C (MMC).
Spotify | AppleDownload MP3 (mp3, 29:48 mins)

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given